Browsing by Subject "Drug Screening Assays, Antitumor"
Now showing items 1-2 of 2
-
Novel diarylamides and diarylureas with N-substitution dependent activity against medulloblastoma
(2021)Medulloblastoma – highly aggressive and heterogeneous tumours of the cerebellum – account for 15–20% of all childhood brain tumours, and are the most common high-grade childhood embryonal tumour of the central nervous ... -
Tumor chemosensitivity assays are helpful for personalized Cytotoxic treatments in cancer patients
(2021)Tumor chemosensitivity assays (TCAs), also known as drug response assays or individualized tumor response tests, have been gaining attention over the past few decades. Although there have been strong positive correlations ...